CVS Health (NYSE:CVS) Stock Rating Lowered by Wall Street Zen

CVS Health (NYSE:CVS) was downgraded by Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Saturday, Wall Street Zen reports.

CVS has been the topic of a number of other research reports. HSBC reiterated a “hold” rating and set a $103.00 target price on shares of CVS Health in a report on Monday, July 6th. Truist Financial lifted their price target on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Barclays upped their price target on CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a report on Thursday. Finally, UBS Group reissued a “buy” rating on shares of CVS Health in a research report on Tuesday, September 22nd. Twenty-two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average target price of $107.24.

CVS Health Trading Down 0.1%

NYSE:CVS opened at $86.40 on Friday. The company has a 50-day moving average price of $94.68 and a 200-day moving average price of $92.01. The stock has a market cap of $110.50 billion, a price-to-earnings ratio of 22.86, a P/E/G ratio of 0.84 and a beta of 0.60. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. CVS Health has a 12 month low of $69.51 and a 12 month high of $110.68.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter in the previous year, the company earned $1.81 earnings per share. CVS Health’s quarterly revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts predict that CVS Health will post 8.02 EPS for the current year.

Institutional Investors Weigh In On CVS Health

Hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new position in shares of CVS Health in the 2nd quarter worth about $12,747,462,000. State Street Corp boosted its stake in CVS Health by 26.3% in the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock worth $7,751,205,000 after purchasing an additional 15,604,883 shares in the last quarter. Wellington Management Group LLP grew its position in CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after purchasing an additional 11,233,381 shares during the last quarter. Bank of America Corp DE increased its stake in CVS Health by 148.0% during the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after purchasing an additional 13,836,701 shares in the last quarter. Finally, Capital International Investors raised its holdings in CVS Health by 3.4% in the fourth quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock worth $2,189,793,000 after buying an additional 900,153 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

About CVS Health

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company’s major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.